Delphi Management Inc /Ma/ Abb Vie Inc. Transaction History

Delphi Management Inc /Ma/

$103 Million
Q4 2024

A detailed history of Delphi Management Inc /Ma/ transactions in Abb Vie Inc. stock. As of the latest transaction made, Delphi Management Inc /Ma/ holds 6,620 shares of ABBV stock, worth $1.36 Million. This represents 1.14% of its overall portfolio holdings.

Number of Shares

6,620

Previous 6,693 1.09%

Holding current value

$1.36 Million

Previous $1.32 Million 11.04%

% of portfolio

1.14%

Previous 1.2%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 10, 2025	SELL	$164.99 - $203.87 $12,044 - $14,882	-73 Reduced 1.09%	6,620 $1.18 Million
Q3 2024 Feb 10, 2025	SELL	$163.84 - $199.33 $200,704 - $244,179	-1,225 Reduced 15.47%	6,693 $1.32 Million
Q2 2024 Aug 23, 2024	BUY	$154.79 - $180.76 $1,857 - $2,169	12 Added 0.15%	7,918 $1.36 Million
Q1 2024 May 21, 2024	SELL	$159.82 - $182.1 $215,916 - $246,017	-1,351 Reduced 14.59%	7,906 $1.44 Million
Q4 2023 May 20, 2024	BUY	$137.6 - $154.97 $181,081 - $203,940	1,316 Added 16.57%	9,257 $1.12 Million
Q3 2023 Jan 25, 2024	BUY	$133.59 - $154.65 $2,137 - $2,474	16 Added 0.2%	7,941 $1.18 Million
Q2 2023 Aug 28, 2023	SELL	$132.51 - $164.9 $31,007 - $38,586	-234 Reduced 2.87%	7,925 $1.07 Million
Q4 2022 Jul 11, 2023	SELL	$138.31 - $165.87 $538,717 - $646,063	-3,895 Reduced 32.31%	8,159 $1.32 Million
Q4 2021 Feb 15, 2022	BUY	$107.43 - $135.93 $42,542 - $53,828	396 Added 3.4%	12,054 $1.63 Million
Q3 2021 Nov 15, 2021	BUY	$106.4 - $120.78 $13,406 - $15,218	126 Added 1.09%	11,658 $1.26 Million
Q2 2021 Aug 16, 2021	BUY	$105.21 - $117.21 $24,829 - $27,661	236 Added 2.09%	11,532 $1.3 Million
Q1 2021 May 14, 2021	SELL	$102.3 - $112.62 $220,661 - $242,921	-2,157 Reduced 16.03%	11,296 $1.22 Million
Q3 2019 Oct 07, 2019	SELL	$62.98 - $75.72 $25,695 - $30,893	-408 Reduced 2.94%	13,453 $1.02 Million
Q2 2019 Aug 20, 2019	SELL	$65.7 - $83.98 $1,314 - $1,679	-20 Reduced 0.14%	13,861 $1.01 Million
Q1 2019 May 13, 2019	SELL	$77.14 - $90.79 $348,981 - $410,733	-4,524 Reduced 24.58%	13,881 $1.12 Million
Q4 2018 Feb 22, 2019	BUY	$77.85 - $96.01 $37,056 - $45,700	476 Added 2.65%	18,405 $1.7 Million
Q3 2018 Nov 13, 2018	SELL	$88.91 - $98.84 $52,634 - $58,513	-592 Reduced 3.2%	17,929 $1.7 Million
Q2 2018 Aug 20, 2018	BUY	$89.78 - $106.23 $1.66 Million - $1.97 Million	18,521 New	18,521 $1.71 Million

Others Institutions Holding ABBV

# of Institutions

4,111

Shares Held

1.28B

Call Options Held

16.7M

Put Options Held

15M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $363B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Delphi Management Inc /Ma/, based on Form 13F filings with the SEC.

News

Stay updated on Delphi Management Inc /Ma/ with notifications on news.

Account

Delphi Management Inc /Ma/ Abb Vie Inc. Transaction History